MTOR and neoplasm: Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) is a transmembrane receptor that drives tumor progression by activating dual signaling pathways, namely Wnt/β-catenin and PI3K-AKT-mTOR (34).